Limited Role of Antibody in Clearance of Streptococcus Pneumoniae in a Murine Model of Colonization
Overview
Authors
Affiliations
Colonization is the first step in the interaction between Streptococcus pneumoniae and its human host. To better understand the mechanisms contributing to natural carriage, a mouse model of pneumococcal colonization was developed with a clinical isolate of S. pneumoniae previously characterized in experimental colonization of humans. Similar to carriage events in humans, colonization of mice was self-limited and there was no evidence of lower respiratory tract or invasive disease. Carriage induced a serum antibody response to whole pneumococci that was associated temporally with clearance of colonization in three inbred strains of mice. Individual mice, however, did not demonstrate a correlation between the density of colonization and amounts of serum or of mucosal antibodies, including antibodies of different isotypes and antigenic specificities. The role of antibody in the clearance of carriage was then examined in mice with genetic defects in humoral immunity. xid mice, which have deficient responses to polysaccharide antigens, cleared colonization at the same rate as the parent strain. Finally, we showed that microMT mice, which lack mature B cells and fail to produce antibody, were unaffected in the density or duration of colonization. These results demonstrate that antibody is not required for clearance of pneumococcal colonization in mice.
Croucher N, Campo J, Le T, Pablo J, Hung C, Teng A Nat Commun. 2024; 15(1):355.
PMID: 38191887 PMC: 10774285. DOI: 10.1038/s41467-023-44584-2.
Effects of Capsular Polysaccharide amount on Pneumococcal-Host interactions.
Zhu J, Abruzzo A, Wu C, Bee G, Pironti A, Putzel G PLoS Pathog. 2023; 19(8):e1011509.
PMID: 37540710 PMC: 10431664. DOI: 10.1371/journal.ppat.1011509.
Olwagen C, Izu A, Mutsaerts E, Jose L, Koen A, Downs S Lancet Child Adolesc Health. 2023; 7(5):326-335.
PMID: 36934731 PMC: 10127219. DOI: 10.1016/S2352-4642(23)00025-1.
Neonatal Fc Receptor-Targeted Therapies in Neurology.
Nelke C, Spatola M, Schroeter C, Wiendl H, Lunemann J Neurotherapeutics. 2022; 19(3):729-740.
PMID: 34997443 PMC: 9294083. DOI: 10.1007/s13311-021-01175-7.
Zangari T, Ortigoza M, Lokken-Toyli K, Weiser J mBio. 2021; 12(1).
PMID: 33593970 PMC: 8545127. DOI: 10.1128/mBio.03589-20.